MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Tandem Diabetes Care Operating Expenses 2011-2026 | TNDM
Annual Operating Expenses Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 159 M | 158 M | 601 M | 506 M | 354 M | 268 M | 211 M | 134 M | 107 M | 102 M | 95.6 M | 90.9 M | 55.6 M | 31.7 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 601 M | 31.7 M | 205 M |
Quarterly Operating Expenses Tandem Diabetes Care
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 157 M | 178 M | 239 M | - | 151 M | 144 M | 136 M | - | 121 M | 141 M | 211 M | - | 152 M | 114 M | 106 M | 101 M | 89 M | 87 M | 76.5 M | 71.9 M | 66.3 M | 66.4 M | 63.8 M | 58.1 M | 56.7 M | 51.8 M | 44.4 M | 41 M | 37.5 M | 29.1 M | 26.9 M | 27 M | 25 M | 27 M | 28 M | 23.4 M | 26.8 M | 25.2 M | 26.2 M | 24.7 M | 24.2 M | 23.5 M | 23.2 M | 24 M | 23.4 M | 21.8 M | 21.7 M | 17.7 M | 14.7 M | 14.1 M | 9.21 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 239 M | 9.21 M | 68.1 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K |  USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.17 | -1.55 % | $ 119 M |  France |
 |
Electromed
ELMD
|
40.3 M | $ 25.61 | -1.52 % | $ 217 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Globus Medical
GMED
|
547 M | $ 92.82 | -0.94 % | $ 12.6 B | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.19 | 0.84 % | $ 1.78 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.09 | -1.5 % | $ 1.27 M | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.25 | 0.77 % | $ 62.8 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 12.17 | -1.22 % | $ 482 M |  Curacao |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.64 | 5.38 % | $ 39.8 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.11 | -0.94 % | $ 315 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.38 | 1.26 % | $ 6.6 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 324.55 | -1.36 % | $ 124 B | USA |
 |
Tactile Systems Technology
TCMD
|
221 M | $ 23.66 | -2.39 % | $ 541 M | USA |
 |
TELA Bio
TELA
|
88.1 M | $ 0.77 | -4.03 % | $ 36.1 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
TransMedics Group
TMDX
|
254 M | $ 104.23 | -3.6 % | $ 3.54 B | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.25 | -2.23 % | $ 50.9 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 5.46 | -0.36 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.73 | -0.57 % | $ 369 M | USA |
 |
Varex Imaging Corporation
VREX
|
318 M | $ 12.58 | -1.0 % | $ 521 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.73 | -1.06 % | $ 384 M | USA |
 |
Vivos Therapeutics
VVOS
|
30.4 M | $ 0.88 | 2.54 % | $ 9.04 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 63.09 | -0.5 % | $ 3.44 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.05 | -2.78 % | $ 17.8 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 37.54 | -0.87 % | $ 1.17 B | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 55.68 | 1.11 % | $ 1.64 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 84.75 | -0.7 % | $ 2.94 B | USA |